NIVALIS THERAPEUTICS INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	13
#2	EPO (European Patent Office)	10
#3	WIPO (World Intellectual Property Organization)	6
#4	Hong Kong	5
#5	Australia	4
#6	Hungary	4
#7	Israel	3
#8	Slovenia	3
#9	Japan	2
#10	Serbia	2

#	Technology
#1	Medical preparations
#2	Heterocyclic compounds
#3	Therapeutic chemical compounds
#4	Acyclic or carbocyclic compounds
#5	Microorganisms
#6	Enzymes
#7	Organic chemistry methods

Publication	Filing date	Title
WO2017151725A1	2017-03-01	Formulations of an s-nitrosoglutathione reductase inhibitor
WO2017062611A1	2016-10-06	Methods for the treatment of cystic fibrosis
WO2017044788A1	2016-09-09	Formulations of an s-nitrosoglutathione reductase inhibitor
EP3204010A1	2015-10-08	Methods for the treatment of cystic fibrosis
AU2015224464A1	2015-09-10	Novel substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
WO2015143376A1	2015-03-20	Novel compounds for the treatment of cystic fibrosis
EP2651871A1	2011-12-16	Novel substituted bicyclic aromatic compounds as s-nitrosoglutathione reductase inhibitors
EP2592934A1	2011-07-08	Novel dihydropyridin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
EP2315591A1	2009-08-14	Novel pyrrole inhibitors of s-nitrosoglutathione reductase as therapeutic agents